Linear atrophoderma of Moulin: Difference between revisions
From WikiMD's Wellness Encyclopedia
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Linear atrophoderma of Moulin | |||
| synonyms = | |||
| specialty = [[Dermatology]] | |||
| symptoms = [[Hyperpigmentation]], [[atrophy]] | |||
| onset = [[Childhood]] or [[adolescence]] | |||
| duration = [[Chronic]] | |||
| causes = Unknown | |||
| risks = | |||
| diagnosis = [[Clinical diagnosis]] | |||
| differential = [[Linear scleroderma]], [[Morphea]] | |||
| treatment = None specific | |||
| prognosis = Generally [[benign]] | |||
| frequency = Rare | |||
}} | |||
'''Linear Atrophoderma of Moulin''' is a rare, idiopathic, acquired, linear dermatosis that was first described by Moulin et al. in 1992. It is characterized by hyperpigmented, atrophic, linear bands that follow the lines of Blaschko. The onset is usually in childhood or early adolescence. The pathogenesis of this condition is unknown. | '''Linear Atrophoderma of Moulin''' is a rare, idiopathic, acquired, linear dermatosis that was first described by Moulin et al. in 1992. It is characterized by hyperpigmented, atrophic, linear bands that follow the lines of Blaschko. The onset is usually in childhood or early adolescence. The pathogenesis of this condition is unknown. | ||
== Clinical Features == | == Clinical Features == | ||
The clinical features of Linear Atrophoderma of Moulin include the following: | The clinical features of Linear Atrophoderma of Moulin include the following: | ||
* '''Onset''': The onset is usually in childhood or early adolescence. | * '''Onset''': The onset is usually in childhood or early adolescence. | ||
* '''Lesions''': The lesions are hyperpigmented, atrophic, linear bands that follow the lines of [[Blaschko]]. | * '''Lesions''': The lesions are hyperpigmented, atrophic, linear bands that follow the lines of [[Blaschko]]. | ||
* '''Distribution''': The distribution of the lesions is usually unilateral and segmental. The trunk and limbs are the most commonly affected areas. | * '''Distribution''': The distribution of the lesions is usually unilateral and segmental. The trunk and limbs are the most commonly affected areas. | ||
* '''Symptoms''': The condition is usually asymptomatic. | * '''Symptoms''': The condition is usually asymptomatic. | ||
== Diagnosis == | == Diagnosis == | ||
The diagnosis of Linear Atrophoderma of Moulin is primarily clinical, based on the characteristic appearance of the lesions and their distribution. Histopathological examination of the lesions shows a decrease in the amount of subcutaneous fat and dermal collagen, with no inflammation or changes in the overlying epidermis. | The diagnosis of Linear Atrophoderma of Moulin is primarily clinical, based on the characteristic appearance of the lesions and their distribution. Histopathological examination of the lesions shows a decrease in the amount of subcutaneous fat and dermal collagen, with no inflammation or changes in the overlying epidermis. | ||
== Treatment == | == Treatment == | ||
There is no specific treatment for Linear Atrophoderma of Moulin. Management is primarily supportive, with the aim of improving the cosmetic appearance of the lesions. Options may include the use of topical corticosteroids, calcineurin inhibitors, and cosmetic camouflage. | There is no specific treatment for Linear Atrophoderma of Moulin. Management is primarily supportive, with the aim of improving the cosmetic appearance of the lesions. Options may include the use of topical corticosteroids, calcineurin inhibitors, and cosmetic camouflage. | ||
== Prognosis == | == Prognosis == | ||
The prognosis of Linear Atrophoderma of Moulin is generally good. The condition is not associated with any systemic involvement or malignancy. However, the cosmetic impact of the lesions can be significant. | The prognosis of Linear Atrophoderma of Moulin is generally good. The condition is not associated with any systemic involvement or malignancy. However, the cosmetic impact of the lesions can be significant. | ||
== See Also == | == See Also == | ||
* [[List of cutaneous conditions]] | * [[List of cutaneous conditions]] | ||
* [[Lines of Blaschko]] | * [[Lines of Blaschko]] | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Skin conditions]] | [[Category:Skin conditions]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 01:45, 4 April 2025
| Linear atrophoderma of Moulin | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Hyperpigmentation, atrophy |
| Complications | N/A |
| Onset | Childhood or adolescence |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown |
| Risks | |
| Diagnosis | Clinical diagnosis |
| Differential diagnosis | Linear scleroderma, Morphea |
| Prevention | N/A |
| Treatment | None specific |
| Medication | N/A |
| Prognosis | Generally benign |
| Frequency | Rare |
| Deaths | N/A |
Linear Atrophoderma of Moulin is a rare, idiopathic, acquired, linear dermatosis that was first described by Moulin et al. in 1992. It is characterized by hyperpigmented, atrophic, linear bands that follow the lines of Blaschko. The onset is usually in childhood or early adolescence. The pathogenesis of this condition is unknown.
Clinical Features[edit]
The clinical features of Linear Atrophoderma of Moulin include the following:
- Onset: The onset is usually in childhood or early adolescence.
- Lesions: The lesions are hyperpigmented, atrophic, linear bands that follow the lines of Blaschko.
- Distribution: The distribution of the lesions is usually unilateral and segmental. The trunk and limbs are the most commonly affected areas.
- Symptoms: The condition is usually asymptomatic.
Diagnosis[edit]
The diagnosis of Linear Atrophoderma of Moulin is primarily clinical, based on the characteristic appearance of the lesions and their distribution. Histopathological examination of the lesions shows a decrease in the amount of subcutaneous fat and dermal collagen, with no inflammation or changes in the overlying epidermis.
Treatment[edit]
There is no specific treatment for Linear Atrophoderma of Moulin. Management is primarily supportive, with the aim of improving the cosmetic appearance of the lesions. Options may include the use of topical corticosteroids, calcineurin inhibitors, and cosmetic camouflage.
Prognosis[edit]
The prognosis of Linear Atrophoderma of Moulin is generally good. The condition is not associated with any systemic involvement or malignancy. However, the cosmetic impact of the lesions can be significant.
See Also[edit]
References[edit]
<references />
